What should you know about bone marrow flow cytometry analysis?

A marrow sample is mixed with labelled antibodies that attach to selected features on or within cells. The instrument passes cells through a laser beam and records the resulting light signals. The pattern can support assessment of leukaemia, lymphoma, plasma-cell disorders, and other blood or marrow conditions, but it is interpreted with the rest of the diagnostic work-up.

Results may describe a cell population as normal, atypical, clonal, or showing a particular immunophenotype. An immunophenotype is the combination of markers detected on the tested cells. That combination can help narrow the type and maturity of a cell population. Flow cytometry does not replace examination of the marrow's structure under a microscope, chromosome or gene testing, blood counts, or clinical assessment. A result with no abnormal population detected also needs context because sample quality and the cells present affect interpretation.

Arrange follow-up with the clinician who ordered the marrow test so the flow result can be reviewed alongside the biopsy report and other laboratory findings. Do not change prescribed treatment based on a single line or marker in the report. If the sample was inadequate or findings do not match the wider picture, the team may discuss repeat sampling or a different test. Keep the biopsy site clean and follow the procedure team's instructions for dressings, activity, and pain relief.

After marrow sampling, contact the treating team promptly for bleeding that continues despite firm pressure, increasing redness or swelling, drainage, fever, or pain that is becoming more severe. Seek urgent help for heavy bleeding, fainting, breathing difficulty, chest pain, new confusion, or sudden severe weakness. Flow cytometry itself is performed on the collected sample, so immediate physical concerns generally relate to the sampling procedure or the underlying illness rather than the laboratory analysis.

Useful questions include which cell population was examined, whether an abnormal or clonal population was found, and how the marker pattern fits the suspected diagnosis. Ask whether the sample quality limited the analysis and which microscopy, chromosome, gene, or blood-test results are still pending. If you are already receiving treatment, ask whether this test is being used to clarify the diagnosis, measure response, or investigate a possible return of disease.